A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection
This Registry is designed to provide long term clinical and virologic follow up in participants who have achieved sustained virologic response (SVR) while participating in a previous Gilead sponsored hepatitis C virus (HCV) study. This long term follow up study is observational and no treatment is provided for HCV.
Trial Website: https://clinicaltrials.gov/show/NCT01457755
Are you Eligible? (Inclusion Criteria)
Inclusion Criteria:
- Have previously participated in a Gilead-sponsored hepatitis C study and received at least one Gilead oral antiviral agent (OAV)
- Have achieved SVR in a Gilead-sponsored study, as defined in the original treatment protocol
- Provide written, informed consent
- Be willing and able to comply with the visit schedule and protocol-mandated procedures
Exclusion Criteria:
- Individuals planning to start a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up Registry
- History of clinically significant illness or any other major medical disorder that may interfere with follow up, assessments, or compliance with the protocol
Specialty Area(s)
Liver